These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 26609645)

  • 1. Basic aspects in selecting a suitable transgenic rodent model for Alzheimer's disease.
    Balmus IM; Ciobica A; Negura A; Negura L; Anton E
    Psychiatr Danub; 2015 Dec; 27(4):338-45. PubMed ID: 26609645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rodent models for Alzheimer's disease drug discovery.
    Puzzo D; Gulisano W; Palmeri A; Arancio O
    Expert Opin Drug Discov; 2015 Jul; 10(7):703-11. PubMed ID: 25927677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Why have transgenic rodent models failed to successfully mimic Alzheimer's disease. How can we develop effective drugs without them?
    Franco R; Martínez-Pinilla E; Navarro G
    Expert Opin Drug Discov; 2019 Apr; 14(4):327-330. PubMed ID: 30775940
    [No Abstract]   [Full Text] [Related]  

  • 4. Alzheimer's disease: old problem, new views from transgenic and viral models.
    Jaworski T; Dewachter I; Seymour CM; Borghgraef P; Devijver H; Kügler S; Van Leuven F
    Biochim Biophys Acta; 2010 Oct; 1802(10):808-18. PubMed ID: 20332023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Therapeutic strategies and Alzheimer's disease: contribution of animal models].
    Chabrier PE
    Ann Pharm Fr; 2009 Mar; 67(2):97-103. PubMed ID: 19298893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The treatment of Alzheimer's disease using Chinese medicinal plants: from disease models to potential clinical applications.
    Su Y; Wang Q; Wang C; Chan K; Sun Y; Kuang H
    J Ethnopharmacol; 2014 Mar; 152(3):403-23. PubMed ID: 24412377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Revisiting rodent models: Octodon degus as Alzheimer's disease model?
    Steffen J; Krohn M; Paarmann K; Schwitlick C; Brüning T; Marreiros R; Müller-Schiffmann A; Korth C; Braun K; Pahnke J
    Acta Neuropathol Commun; 2016 Aug; 4(1):91. PubMed ID: 27566602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How does a researcher choose the best rodent model for their Alzheimer's disease drug discovery study?
    Van Dam D; De Deyn PP
    Expert Opin Drug Discov; 2020 Mar; 15(3):269-271. PubMed ID: 31592694
    [No Abstract]   [Full Text] [Related]  

  • 9. The contribution of transgenic and nontransgenic animal models in Alzheimer's disease drug research and development.
    Mhillaj E; Cuomo V; Mancuso C
    Behav Pharmacol; 2017 Apr; 28(2 and 3-Spec Issue):95-111. PubMed ID: 28177983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Searching for new animal models of Alzheimer's disease.
    Epis R; Gardoni F; Marcello E; Genazzani A; Canonico PL; Di Luca M
    Eur J Pharmacol; 2010 Jan; 626(1):57-63. PubMed ID: 19836370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Commentary to the recently published review "Drug pipeline in neurodegeneration based on transgenic mice models of Alzheimer's disease" by Li, Evrahimi and Schluesener. Ageing Res. Rev. 2013 Jan;12(1):116-40.
    Windisch M; Flunkert S; Havas D; Hutter-Paier B
    Ageing Res Rev; 2013 Sep; 12(4):852-4. PubMed ID: 23851053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Animal systems in the development of treatments for Alzheimer's disease: challenges, methods, and implications.
    Sabbagh JJ; Kinney JW; Cummings JL
    Neurobiol Aging; 2013 Jan; 34(1):169-83. PubMed ID: 22464953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mouse Models of Alzheimer's Disease.
    Esquerda-Canals G; Montoliu-Gaya L; Güell-Bosch J; Villegas S
    J Alzheimers Dis; 2017; 57(4):1171-1183. PubMed ID: 28304309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selecting a mouse model of Alzheimer's disease.
    Chin J
    Methods Mol Biol; 2011; 670():169-89. PubMed ID: 20967591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alzheimer's disease in the zebrafish: where can we take it?
    Caramillo EM; Echevarria DJ
    Behav Pharmacol; 2017 Apr; 28(2 and 3-Spec Issue):179-186. PubMed ID: 28177980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug pipeline in neurodegeneration based on transgenic mice models of Alzheimer's disease.
    Li C; Ebrahimi A; Schluesener H
    Ageing Res Rev; 2013 Jan; 12(1):116-40. PubMed ID: 22982398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic targets from a Drosophila model of Alzheimer's disease.
    Crowther DC; Kinghorn KJ; Page R; Lomas DA
    Curr Opin Pharmacol; 2004 Oct; 4(5):513-6. PubMed ID: 15351357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. We can treat Alzheimer's disease successfully in mice but not in men: failure in translation? A perspective.
    Windisch M
    Neurodegener Dis; 2014; 13(2-3):147-50. PubMed ID: 24401335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Research progress of transgenic Drosophila model of Alzheimer disease].
    Tan Y; Ji YB; Zhao J
    Yao Xue Xue Bao; 2013 Mar; 48(3):333-6. PubMed ID: 23724643
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.